Top 15 stocks in focus today: HDFC, Biocon, Airtel, Laurus Labs
Equity tips:- Biocon receives EU regulator nod for trastuzumab biosimilar. HDFC to dilute stake in asset management unit via IPO. To hold 50.01% stake in the AMC business post stake dilution. Standard Life to hold 24.99%. Bharti Airtel and Vodafone India are keen to acquire some spectrum from RCom to add to their airwave holdings in key markets, people familiar with the matter said. The Anil Ambani-owned telco’s lenders are selling the spectrum to try and recover part of their Rs45,000cr dues. Dr Reddy’s Laboratories said a German regulatory authority has allowed the company’s Visakhapatnam-based plant to restart production for the EU market. Shilpa Medicare says NCLT approves scheme of merger of Navya Biologicals with self. Laurus Labs receives maiden tentative approval from USFDA for Tenofovir Disoproxil Fumarate tablets. Mirza International receives MCA approval for scheme of merger between Hi-Life Fabricators and se...